| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Carla M Cuda | Q79912675 |
| P2093 | author name string | Harris Perlman | |
| FuNien Tsai | |||
| P2860 | cites work | Treatment for lupus nephritis | Q24202572 |
| Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors | Q24310559 | ||
| Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade | Q24311006 | ||
| cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms | Q24311676 | ||
| TNF-alpha induces two distinct caspase-8 activation pathways | Q24313656 | ||
| Outcomes of children with proliferative lupus nephritis: the role of protocol renal biopsy | Q79864046 | ||
| Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18 | Q80419619 | ||
| Immature myeloid and plasmacytoid dendritic cells infiltrate renal tubulointerstitium in patients with lupus nephritis | Q80481438 | ||
| Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity | Q80703822 | ||
| Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus | Q81000909 | ||
| Genomic view of systemic autoimmunity in MRLlpr mice | Q82689901 | ||
| Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis | Q82691122 | ||
| The landscape after LUNAR: rituximab's crater-filled path | Q83200527 | ||
| Macrophages in kidney repair and regeneration | Q83356478 | ||
| DNase1 activity in systemic lupus erythematosus patients with and without nephropathy | Q84756756 | ||
| X-linked IAP is a direct inhibitor of cell-death proteases | Q24318710 | ||
| BID: a novel BH3 domain-only death agonist | Q24320091 | ||
| IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases | Q24533214 | ||
| Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis | Q24606320 | ||
| Therapeutic targeting of macrophages in lupus nephritis | Q26796277 | ||
| Phagocytosis of apoptotic cells in homeostasis | Q28081044 | ||
| BH3-only proteins: a 20-year stock-take | Q28085220 | ||
| Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition | Q28115131 | ||
| Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins | Q28117928 | ||
| Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity | Q28138855 | ||
| Marginal-zone B cells | Q28201000 | ||
| The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex | Q28221276 | ||
| Fas ligation on macrophages enhances IL-1R1-Toll-like receptor 4 signaling and promotes chronic inflammation | Q28248826 | ||
| Dietary modulation of the microbiome affects autoinflammatory disease | Q28249017 | ||
| Siglecs and their roles in the immune system | Q28294469 | ||
| Cells in the marginal zone of the spleen | Q28294678 | ||
| Apoptotic cell responses in the splenic marginal zone: a paradigm for immunologic reactions to apoptotic antigens with implications for autoimmunity | Q28385358 | ||
| Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis | Q28584976 | ||
| Survival function of the FADD-CASPASE-8-cFLIP(L) complex | Q28589465 | ||
| BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis | Q28594183 | ||
| Alternative activation of macrophages: mechanism and functions | Q29614350 | ||
| Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors | Q29615065 | ||
| Fcgamma receptors as regulators of immune responses | Q29615584 | ||
| The M1 and M2 paradigm of macrophage activation: time for reassessment | Q29615845 | ||
| Nonresolving inflammation | Q29616352 | ||
| Development of monocytes, macrophages, and dendritic cells | Q29616446 | ||
| RIP3 mediates the embryonic lethality of caspase-8-deficient mice | Q29617723 | ||
| The Bcl-2 protein family: arbiters of cell survival | Q29618158 | ||
| Macrophage activation and polarization: nomenclature and experimental guidelines | Q29620642 | ||
| Follicular shuttling of marginal zone B cells facilitates antigen transport | Q30441344 | ||
| The pathogenesis, diagnosis and treatment of lupus nephritis | Q30596968 | ||
| RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL | Q30623992 | ||
| Intramolecular epitope spreading among anti-caspase-8 autoantibodies in patients with silicosis, systemic sclerosis and systemic lupus erythematosus, as well as in healthy individuals | Q30713693 | ||
| Splenectomy may improve the glomerulopathy of type II mixed cryoglobulinemia | Q33332715 | ||
| Splenectomy increases the subsequent risk of systemic lupus erythematosus | Q33427267 | ||
| Association between SLE nephritis and polymorphic variants of the CRP and Fc RIIIa genes | Q58190252 | ||
| The CD95 Receptor: Apoptosis Revisited | Q62734296 | ||
| Bcl-2 Antagonists Kill Plasmacytoid Dendritic Cells From Lupus-Prone Mice and Dampen Interferon-α Production | Q62817627 | ||
| cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1- and RIPK3-dependent manner | Q62817637 | ||
| Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites | Q68013717 | ||
| Studies of lymphoproliferation in MRL-lpr/lpr mice | Q70223568 | ||
| Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome | Q70624757 | ||
| Effect of a specific endothelin A receptor antagonist on murine lupus nephritis | Q72171798 | ||
| Reduced macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-deficient mice results in decreased tubular apoptosis during renal inflammation | Q73100858 | ||
| Rheumatic diseases in an MRL strain of mice with a deficit in the functional Fas ligand | Q73414181 | ||
| Dominant expression of a novel splice variant of caspase-8 in human peripheral blood lymphocytes | Q73910439 | ||
| Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis | Q74301355 | ||
| Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis | Q74455224 | ||
| Bcl-2 controls dendritic cell longevity in vivo | Q74754628 | ||
| The role of autoantibodies in the pathogenesis of lupus nephritis | Q78024285 | ||
| FcR-bearing myeloid cells are responsible for triggering murine lupus nephritis | Q79326796 | ||
| Pathogenic profiles and molecular signatures of antinuclear autoantibodies rescued from NZM2410 lupus mice | Q36399144 | ||
| Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus | Q36403653 | ||
| Attacking cancer's Achilles heel: antagonism of anti-apoptotic BCL-2 family members | Q36601134 | ||
| SIGN-R1, a C-type lectin, enhances apoptotic cell clearance through the complement deposition pathway by interacting with C1q in the spleen | Q36678337 | ||
| What is damaging the kidney in lupus nephritis? | Q36765221 | ||
| Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival | Q36776853 | ||
| Role of chemokines for the localization of leukocyte subsets in the kidney | Q36833384 | ||
| Apoptotic Debris Accumulates on Hematopoietic Cells and Promotes Disease in Murine and Human Systemic Lupus Erythematosus | Q36905990 | ||
| Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation | Q36954601 | ||
| Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity | Q36955782 | ||
| Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury | Q37170815 | ||
| Progression of murine lupus nephritis is linked to acquired renal Dnase1 deficiency and not to up-regulated apoptosis | Q37257125 | ||
| Cutting edge: Primary and secondary effects of CD19 deficiency on cells of the marginal zone | Q37353933 | ||
| Cross-regulation of signaling by ITAM-associated receptors | Q37366524 | ||
| Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. | Q37486571 | ||
| FADD and caspase-8 mediate priming and activation of the canonical and noncanonical Nlrp3 inflammasomes. | Q37601031 | ||
| Cutting edge: Endoplasmic reticulum stress licenses macrophages to produce mature IL-1β in response to TLR4 stimulation through a caspase-8- and TRIF-dependent pathway | Q37604958 | ||
| Sialoadhesin deficiency does not influence the severity of lupus nephritis in New Zealand black x New Zealand white F1 mice. | Q37690188 | ||
| The distribution and function of phosphatidylserine in cellular membranes | Q37700664 | ||
| Regulation of the immune system by the resident intestinal bacteria. | Q37716899 | ||
| Deregulated cell death and lymphocyte homeostasis cause premature lethality in mice lacking the BH3-only proteins Bim and Bmf. | Q37723472 | ||
| The role of defective clearance of apoptotic cells in systemic autoimmunity. | Q37739807 | ||
| Role for toll-like receptors in autoimmune disease: The example of systemic lupus erythematosus | Q37801738 | ||
| Alternative Macrophage Activation and Metabolism | Q37804862 | ||
| Homeostatic and pathogenic role of renal dendritic cells | Q37879906 | ||
| Contributions of dendritic cells and macrophages to intestinal homeostasis and immune defense | Q38080684 | ||
| Current management of lupus nephritis | Q38163138 | ||
| Monocytes and macrophages: developmental pathways and tissue homeostasis | Q38214042 | ||
| The effect of cell death in the initiation of lupus nephritis. | Q38231647 | ||
| Necroptosis and its role in inflammation | Q38319916 | ||
| Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study | Q38466691 | ||
| Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells | Q38623614 | ||
| The Kidney Biopsy in Lupus Nephritis: Past, Present, and Future | Q38634789 | ||
| Biologics for the treatment of autoimmune renal diseases. | Q38763327 | ||
| Ro52/SSA sensitizes cells to death receptor-induced apoptosis by down-regulating c-FLIP(L). | Q39404426 | ||
| RIG-I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase-8-mediated cleavage of the RIP1 protein | Q39573761 | ||
| Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus | Q39581032 | ||
| Bim-Bcl-2 homology 3 mimetic therapy is effective at suppressing inflammatory arthritis through the activation of myeloid cell apoptosis | Q39885694 | ||
| The Sjogren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death | Q40284365 | ||
| Caspase-8 promotes cell motility and calpain activity under nonapoptotic conditions | Q40291610 | ||
| The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases | Q40341729 | ||
| Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice. | Q40425124 | ||
| Cellular FLIP (long form) regulates CD8+ T cell activation through caspase-8-dependent NF-kappa B activation | Q40432682 | ||
| Cutting Edge: defective follicular exclusion of apoptotic antigens due to marginal zone macrophage defects in autoimmune BXD2 mice. | Q40773152 | ||
| Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease | Q42459225 | ||
| Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids. | Q43472878 | ||
| Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages | Q43514448 | ||
| Increased tubulointerstitial recruitment of human CD141(hi) CLEC9A(+) and CD1c(+) myeloid dendritic cell subsets in renal fibrosis and chronic kidney disease | Q43855997 | ||
| Macrophages and fibrosis: How resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repair | Q44163378 | ||
| Fc receptors | Q44298973 | ||
| Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis | Q44502162 | ||
| Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics | Q44598743 | ||
| Murine monoclonal anti-DNA antibodies bind directly to glomerular antigens and form immune deposits | Q45008271 | ||
| Phosphocholine as a pattern recognition ligand for CD36. | Q45275915 | ||
| Q222R polymorphism in DNAse I gene is a risk factor for nephritis in South Indian SLE patients | Q45693668 | ||
| The Bcl-2 family antagonist ABT-737 significantly inhibits multiple animal models of autoimmunity. | Q45983884 | ||
| Differential expression of factors involved in the intrinsic and extrinsic apoptotic pathways in juvenile systemic lupus erythematosus | Q46130093 | ||
| Apoptotic cell recognition: will the real phosphatidylserine receptor(s) please stand up? | Q46796831 | ||
| Factors associated with poor outcomes in patients with lupus nephritis | Q46840865 | ||
| Accelerated macrophage apoptosis induces autoantibody formation and organ damage in systemic lupus erythematosus | Q46925835 | ||
| Nucleosomes are exposed at the cell surface in apoptosis. | Q47579101 | ||
| A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells | Q47631638 | ||
| Splenectomy increases the subsequent risk of systemic lupus erythematosus: a word of caution | Q48089976 | ||
| Cellular FLIP Inhibits Myeloid Cell Activation by Suppressing Selective Innate Signaling. | Q48151091 | ||
| Non-apoptotic role of BID in inflammation and innate immunity | Q50521157 | ||
| Sialoadhesin deficiency ameliorates myelin degeneration and axonopathic changes in the CNS of PLP overexpressing mice. | Q52003587 | ||
| Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. | Q53183279 | ||
| Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations. | Q53363185 | ||
| MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes. | Q53398443 | ||
| Polymorphism of the FcgammaRIIalpha IgG receptor in patients with lupus nephritis and glomerulopathy. | Q53634333 | ||
| Association of FAS and FAS ligand genes polymorphism and risk of systemic lupus erythematosus. | Q54231271 | ||
| Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome. | Q54464120 | ||
| Enhanced dendritic cell survival attenuates lipopolysaccharide-induced immunosuppression and increases resistance to lethal endotoxic shock. | Q54534377 | ||
| Decreased expressions of the TNF-alpha signaling adapters in peripheral blood mononuclear cells (PBMCs) are correlated with disease activity in patients with systemic lupus erythematosus. | Q54561488 | ||
| Dendritic cells in renal biopsies of patients with acute tubulointerstitial nephritis. | Q54568887 | ||
| Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice. | Q54632752 | ||
| Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis | Q56335982 | ||
| VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia | Q56963014 | ||
| C1q and systemic lupus erythematosus | Q57089594 | ||
| Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies | Q57089602 | ||
| Development of autoimmune nephritis in genetically asplenic and splenectomized BAFF transgenic mice | Q57212152 | ||
| The FcγRIIIA-F158 allele is a risk factor for the development of lupus nephritis: A meta-analysis | Q57332141 | ||
| Loss of function of a lupus-associated FcγRIIb polymorphism through exclusion from lipid rafts | Q57369625 | ||
| Genetic Segregation of Spontaneous Erosive Arthritis and Generalized Autoimmune Disease in the BXD2 Recombinant Inbred Strain of Mice | Q57982623 | ||
| Requirement of myeloid cell-specific Fas expression for prevention of systemic autoimmunity in mice | Q35791280 | ||
| Deficiency of Bim in dendritic cells contributes to overactivation of lymphocytes and autoimmunity. | Q35828628 | ||
| Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens | Q35901015 | ||
| Dendritic cell and macrophage heterogeneity in vivo | Q35903971 | ||
| BIM deficiency differentially impacts the function of kidney endothelial and epithelial cells through modulation of their local microenvironment | Q35924542 | ||
| Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. | Q35953527 | ||
| Structure and function of renal macrophages and dendritic cells from lupus-prone mice | Q35991361 | ||
| Identification of stage-specific genes associated with lupus nephritis and response to remission induction in (NZB × NZW)F1 and NZM2410 mice. | Q36010662 | ||
| Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation. | Q36012345 | ||
| Interferon-induced mechanosensing defects impede apoptotic cell clearance in lupus | Q36040281 | ||
| The BCL-2 protein family, BH3-mimetics and cancer therapy | Q36067778 | ||
| Cross-species transcriptional network analysis defines shared inflammatory responses in murine and human lupus nephritis | Q36083938 | ||
| Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial. | Q36085018 | ||
| Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils | Q36141195 | ||
| Conditional deletion of caspase-8 in macrophages alters macrophage activation in a RIPK-dependent manner. | Q36168991 | ||
| Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells | Q36228153 | ||
| Class A scavenger receptors regulate tolerance against apoptotic cells, and autoantibodies against these receptors are predictive of systemic lupus | Q36228965 | ||
| Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4. | Q36233089 | ||
| Sialoadhesin promotes rapid proinflammatory and type I IFN responses to a sialylated pathogen, Campylobacter jejuni | Q36233954 | ||
| The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus Nephritis | Q36299959 | ||
| Characterising the immune profile of the kidney biopsy at lupus nephritis flare differentiates early treatment responders from non-responders | Q36302345 | ||
| Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase | Q36371130 | ||
| Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice | Q36375621 | ||
| BH3-only proteins in rheumatoid arthritis: potential targets for therapeutic intervention. | Q33727248 | ||
| Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages | Q33733803 | ||
| Autoreactive marginal zone B cells enter the follicles and interact with CD4+ T cells in lupus-prone mice | Q33798580 | ||
| Caspase-8 acts as a molecular rheostat to limit RIPK1- and MyD88-mediated dendritic cell activation | Q33819040 | ||
| Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis. | Q33877996 | ||
| Activation of NF-kappaB by FADD, Casper, and caspase-8. | Q33897301 | ||
| Bid, a widely expressed proapoptotic protein of the Bcl-2 family, displays lipid transfer activity. | Q34012615 | ||
| Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts | Q34060110 | ||
| Immunologic characteristics of intrarenal T cells: trafficking of expanded CD8+ T cell β-chain clonotypes in progressive lupus nephritis | Q34087313 | ||
| Lupus nephritis: a critical review | Q34299943 | ||
| Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages | Q34319288 | ||
| Activation of caspases-8 and -10 by FLIP(L). | Q34328223 | ||
| Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage | Q34443260 | ||
| FLIP: a novel regulator of macrophage differentiation and granulocyte homeostasis | Q34450721 | ||
| Regulation of steady-state neutrophil homeostasis by macrophages. | Q34542130 | ||
| Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease | Q34602392 | ||
| Soluble fas and the -670 polymorphism of fas in lupus nephritis | Q34611175 | ||
| Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. | Q34659689 | ||
| Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice | Q34729932 | ||
| Commensal microbiota are required for systemic inflammation triggered by necrotic dendritic cells. | Q34751838 | ||
| Apoptotic pathways: the roads to ruin | Q34753431 | ||
| Functional complementation between FADD and RIP1 in embryos and lymphocytes | Q34768810 | ||
| The natural interferon-alpha producing cells in systemic lupus erythematosus | Q35024789 | ||
| Proapoptotic activity of a monomeric smac mimetic on human fibroblast-like synoviocytes from patients with rheumatoid arthritis. | Q35033204 | ||
| A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis | Q35174510 | ||
| Modulation of immune development and function by intestinal microbiota. | Q35235355 | ||
| Caspase-8-mediated cleavage inhibits IRF-3 protein by facilitating its proteasome-mediated degradation | Q35311960 | ||
| Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis | Q35324023 | ||
| Deletion of FADD in macrophages and granulocytes results in RIP3- and MyD88-dependent systemic inflammation | Q35393485 | ||
| CD11c-mediated deletion of Flip promotes autoreactivity and inflammatory arthritis | Q35601082 | ||
| Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement | Q35636552 | ||
| Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms | Q35674290 | ||
| The Spleen Plays No Role in Nephrotoxic Serum Nephritis, but Constitutes a Place of Compensatory Haematopoiesis | Q35738747 | ||
| P921 | main subject | cell death | Q2383867 |
| P304 | page(s) | 74-85 | |
| P577 | publication date | 2016-10-22 | |
| P1433 | published in | Clinical Immunology | Q15752921 |
| P1476 | title | The contribution of the programmed cell death machinery in innate immune cells to lupus nephritis | |
| P478 | volume | 185 |
Search more.